FHL2 and chronic kidney disease: qRT-PCR analysis revealed that in the Fhl2+/+ CKD group, the expression of osteogenic genes, including Col1a1, Ocn and Opn, were significantly upregulated, whereas the expression of the vascular smooth muscle cell marker gene Sm22α was downregulated (Fig. 5g–j).